HB-EGF is a heparin-binding member of the EGF family that was initiall
y identified in the conditioned medium of human macrophages. Soluble m
ature HB-EGF is proteolytically processed from a larger membrane-ancho
red precursor and is a potent mitogen and chemotactic factor for fibro
blasts, smooth muscle cells but not endothelial cells. HB-EGF activate
s two EGF receptor subtypes, HER1 and HER4 and binds to cell surface H
SPG. The transmembrane form of HB-EGF is a juxtacrine growth and adhes
ion factor and is uniquely the receptor for diphtheria toxin. HB-EGF g
ene expression is highly regulated, for example by cytokines, growth f
actors, and transcription factors such as MyoD. HB-EGF has been implic
ated as a participant in a variety of normal physiological processes s
uch as blastocyst implantation and wound healing, and in pathological
processes such as tumor growth, SMC hyperplasia and atherosclerosis. (
C) 1997 Elsevier Science B.V.